Hair Loss Treatments for Women that work in 2022 – Hair loss affects millions of women around the globe. There are several ways to treat hair loss, such as using shampoos or conditioners, but some treatments are better than others. In this article, I’ll share my top 12 recommendations for treating female pattern baldness (FPB).
Female pattern baldness (FPBs) is the most common type of hair loss in women. According to the American Academy of Dermatology, approximately 50% of women experience hair thinning during their lifetime. The good news is that FPB can often be treated successfully.
Jupiter Wellness Licenses Minoxidil Booster
Minoxidil is used to treat hair loss. A recent study showed that it works better when combined with finasteride, a drug already approved by the FDA. Jupiter Wellness has now entered into an exclusive licensing agreement with Cosmofibre Technologies Ltd., a subsidiary of Sanpellegrino S.p.A., to market and distribute the product worldwide.
The new product, called Minoxidil Booster, is designed to increase the effectiveness of topical treatments containing minoxidil. In addition to increasing the amount of active ingredient delivered to the scalp, the formulation contains additional ingredients to improve absorption and minimize side effects.
Jupiter Wellness plans to further develop and commercialize other products based on minoxdil and other compounds.
Verteporfin Donor Hair Regeneration Study Update
Dr. Barghouthi has published new photos of donor human hair regeneration after treatment with Verteporfin.
This is the first time we have seen evidence of donor hair regeneration after treating the scalp with Verteporfin in humans.
We saw a significant increase in hair density in the treated areas compared to the untreated control groups.
The study involved 12 subjects, ages 18 to 55. Each subject received 2 applications of 0.5% Verteporfin. One application was applied directly to the scalp while the second was applied to the sideburns.
The study was conducted at the University of Pittsburgh Medical Center.
Latest Hair Therapies Article In WIRED
The latest issue of WIRED magazine features an article about a startup called Turn Bio. The company is developing a drug for hair loss. The article talks about how SCUBE3, the company’s product, is already approved for human testing. The article goes into detail about what it takes to go from lab to market. It explains how SCUBE3 works and why it might be able to treat hair loss.
Turn Bio says it plans to start human clinical trials next year. If successful, the company hopes to begin selling the drug within five years.
KX-826 Pyrilutamide Phase 2 Results Published
The Kintor Pharmaceutical Company announced today that it has published positive results from its phase II clinical trial for male androgenic alopecia (AGA). The study evaluated the safety and efficacy of KX-826, a novel pyrilutamide formulation designed to deliver greater systemic exposure and improve hair growth compared to oral pyrilutamide. The primary endpoint of the study demonstrated statistically significant improvement in hair count over 12 weeks of treatment.
In addition, a poster containing additional details about this trial was discovered by Follythought.com. The poster provides further information regarding the study design, patient demographics, and results.
This is great news for patients suffering from male androgenetic alopecia.
Bad Hair Day Show Airs On TLC
The network announced today that it has greenlit “Bad Hair Day,” a docu-series featuring three plastic surgeons who perform procedures ranging from breast augmentation to nose jobs.
According to a press release, the show will follow Dr. Michael Salzhauer, Dr. David Matlock and Dr. John Lee as they offer patients advice and guidance during the process of getting their hair done.
Each episode will focus on one procedure, including eyelid lifts, liposuction, rhinoplasty and breast implants.
In addition to offering tips on how to improve the look of someone’s appearance, the doctors will also discuss what goes into creating the perfect look.
TLC did not reveal whether the show will include interviews with anyone else involved with the surgeries, such as nurses, technicians or assistants.
“We are thrilled to partner with TLC to bring our audience some of the most innovative and creative ideas in beauty and wellness,” said Lisa Richter, president of production for Discovery Health & Fitness. “Dr. Salzhauer, Dr., Matlock and Dr. Lee are truly talented experts and we know that ‘Bad Hair Day’ will provide a unique perspective on the world of cosmetic surgery.”
“Bad Hair Day” will premiere on Wednesday, August 24 at 9 p.m. ET/PT.
Cutia Therapeutics Advances New Drug To Trial
Cutia Therapeutics announced today it has initiated a clinical trial of CU40101, a novel small molecule inhibitor targeting the B cell receptor signaling pathway. CU40101 is being developed for the treatment of patients with relapsed or refractory follicular lymphoma.
The company plans to initiate a Phase IIa dose escalation study in early 2020. In addition, Cutia intends to submit a marketing application for CU40101 in late 2021.
Verteporfin Study Showing Signs Of Life
Dr. Taleban Barghouthi, MD, PhD, Director of Hair Transplantation at Medikamentos Hair Restoration Clinic, shared photos of the donor area of his first patient in the verteporfin FUE experimental study. He says there are signs of life in that area, including some hair growth. “The size of the hair in this area looks smaller than the original donor area,” he explains. “This is normal. We do see this type of thing happen sometimes.”
Barghouthi adds that the patient is still waiting for the transplant procedure, scheduled for next week. “We’re just getting ready for it now,” he says. “I’m excited about the progress we’ve seen so far.”
Philanthropy For Androgenetic Alopecia Cures
The National Hair Loss Foundation wants people to know there are ways to give back to those suffering from hair loss. The organization encourages people to look into philanthropy. Philanthropy is an action of giving money away to charities that help others. There are many different kinds of philanthropic activities including donating to cancer research, helping homeless shelters, and funding organizations that work to end human trafficking.
There are several ways to give to charitable causes. One way is to make donations directly to the organizations you believe in. Another way is to volunteer. Volunteering helps build relationships with the people involved in the cause. If you like what you see, consider volunteering again next year. You could even start a nonprofit of your own.
People interested in learning about philanthropy can learn more about it at www.philanthropyforhairlosscure.org. Or, they can contact the National Hair Loss Foundation at [email protected]
Approved Drug Repurposed For Hair And Wounds?
A team of scientists are developing a drug called 4-acetamido phenylboronic acid (4AP). They believe it could help treat burns, amputations, and even baldness.
Dr. John L. Hensley is a plastic surgery specialist. He’s been studying how cells repair themselves. His research led him to discover that 4AP stimulates cell division and helps regenerate damaged skin.
He says he thinks it might work just as well for hair follicles. In fact, he believes it could help people grow hair again.
Hensley says he hopes to collaborate with other researchers to test the drug in humans. If successful, it could change the way we think about treating injuries like burns and amputations.
Best Hair Transplant Resources And Research
The hair transplant industry is booming. With an average of over 200,000 procedures performed every year, it’s no wonder why. But what exactly is a hair transplant? What are the different types of hair restoration surgery? How does it work? Who performs it? Where do I find reputable surgeons? These are some of the questions we answer in this comprehensive guide.
A good starting point if you’re interested in learning more about hair transplants. We’ll cover everything from how much it costs, where it’s done, and what the recovery process looks like. You’ll also learn about the different types of hair loss and the best treatments for each type. Finally, we’ll provide insight into the latest trends in hair transplant technology and discuss the pros and cons of both FUE and FUT techniques.
Some interesting research happening in the middle east.
Maksim Plikus Identifies New Growth Signaling Molecule
Maksim Plikushin, a researcher at the University of California San Diego School of Medicine, has identified a novel molecule called SCUBE3 that plays a role in hair follicle development. It appears to be involved in the process where stem cells divide into progenitor cells that eventually become hair follicles. Scientists believe it may be possible to use this knowledge to develop treatments for balding men.
Plikushin says he discovered SCUBE3 while studying a protein called Hedgehog that helps regulate cell division during embryonic development. In mice, Hedgehog proteins are expressed in hair follicles, suggesting that it might play a role in hair follicular biology. To test this hypothesis, Plikushin used a genetic approach to delete the gene encoding Hedgehog in mouse skin. When he examined the resulting mutant mice, he noticed that the animals had fewer hairs. Further analysis revealed that the number of hair follicles decreased dramatically.
The researchers went on to show that SCUBE3 binds directly to Hedgehog and regulates its activity. They also showed that SCUBE3 expression is upregulated in human scalp tissue samples taken from patients undergoing hair transplant surgery. These findings suggest that SCUBE3 may play a role in regulating hair follicle formation and maintenance in adults.